Cardiac Resynchronization Therapy Device
DeviceCardiac Resynchronization Therapy Device pacing activity, on or off
NCT Number: NCT02247427
The purpose of this study is to determine clinical outcomes related to deactivation of Cardiac Resynchronization Therapy device in subjects with super response.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 2 / Phase 3
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cardiac Resynchronization Therapy Device pacing activity, on or off
Time frame: 12 months
Clinical/Echocardiographic outcome including New York Heart Association class, 6-min walk test, Left ventricular ejection fraction, Left ventricular end- diastolic diameter, Left ventricular end-systolic volume, and Left ventricular end-systolic diameter.
Time frame: 12 months
Number of participants experiencing mortality
Time frame: 12 months
Number of participants experiencing heart failure hospitalization
Time frame: 12 months
Heart failure hospitalization Cardiac Resynchronization Therapy Device intervention for detected episodes.
Yuksek Ihtisas Hospital
Other
Midterm Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01648634
Cardiomyopathies, Cardiomyopathy
Paris, France
View Trial DetailsNCT01261065
Cardiomyopathies, Cardiomyopathy
Houston, Texas, United States
View Trial DetailsNCT02543281
Arrhythmias, Cardiac, Bundle-Branch Block
Portland, Oregon, United States
View Trial DetailsNCT02077010
Cardiomyopathies, Cardiomyopathy
Kansas City, Kansas, United States
View Trial Details